RE: PEEL HUNT NOTE 395P15 Dec 2022 02:56
Mind out for rampers - joined Twitter in November 2022 and now posting on this board
No doubt SPEC is undervalued - but markets loose their common sense with a recession on the horizon - despite the fact people still need eye tests, glasses, and contact lenses. The demand is not going away - but profit levels may be hit over next 18 months.
All companies today are approached by buyers trying their luck - but it doesn't mean management wants to sell out cheaply.
SPEC has problems with its Chinese supply chain becos of the Chinese Gov position on zero-covid but that is now being relaxed. Unfortunately, China is still going to catch a very bad cold because the population is unvaccinated.
SPEC needs to quickly divorce itself from China and find western supply chains. Until then, this company is risky.
There is no doubt this is a good long term value investment - but don't rely on rumours of acquisition........